ID

14118

Descrizione

Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management; ODM derived from: https://clinicaltrials.gov/show/NCT01908075

collegamento

https://clinicaltrials.gov/show/NCT01908075

Keywords

  1. 30/03/16 30/03/16 -
Caricato su

30 marzo 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Asthma NCT01908075

Eligibility Asthma NCT01908075

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01908075
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged: 18-80 years 61-80 years to be non-smokers only
Descrizione

Age | Non-smoker

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0337672
evidence of asthma: a diagnostic code for asthma or two scripts for asthma..
Descrizione

Asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004096
baseline fp/sal therapy: ≥2 prescription for ics/laba therapy as fp/sal
Descrizione

fluticasone | salmeterol | Therapeutic procedure | inhaled steroids | Adrenergic beta-2 Receptor Agonists | Therapeutic procedure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0082607
UMLS CUI [1,2]
C0073992
UMLS CUI [1,3]
C0087111
UMLS CUI [2,1]
C2065041
UMLS CUI [2,2]
C2936789
UMLS CUI [2,3]
C0087111
evidence of continuing therapy: include only patients who receive ≥2 prescriptions for the therapy under study during the outcome year (i.e. ≥1 prescription at the index date and ≥1 other). uk average is 3-4 prescriptions refilled per year, so ≥2 ensures capture of "real-life" data.
Descrizione

Continuous therapeutic procedure | prescription

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0549178
UMLS CUI [2]
C1521941
evidence of switching for economic reasons: fp/sal patients from practices with ≥5 switches to fostair in a 3 month period to minimise data taken from switching of anomalous patients; optimal practices for inclusion are those switching "wholesale" for economic reasons.
Descrizione

Therapy change | fluticasone salmeterol

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3665894
UMLS CUI [2,1]
C0082607
UMLS CUI [2,2]
C0073992
UMLS CUI [2,3]
C0087111
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
any chronic respiratory disease other than asthma
Descrizione

Chronic disease of respiratory system

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0264220
UMLS CUI [2]
C0004096
are receiving maintenance oral steroid therapy during baseline period
Descrizione

Oral steroid therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0087111

Similar models

Eligibility Asthma NCT01908075

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01908075
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age | Non-smoker
Item
aged: 18-80 years 61-80 years to be non-smokers only
boolean
C0001779 (UMLS CUI [1])
C0337672 (UMLS CUI [2])
Asthma
Item
evidence of asthma: a diagnostic code for asthma or two scripts for asthma..
boolean
C0004096 (UMLS CUI [1])
fluticasone | salmeterol | Therapeutic procedure | inhaled steroids | Adrenergic beta-2 Receptor Agonists | Therapeutic procedure
Item
baseline fp/sal therapy: ≥2 prescription for ics/laba therapy as fp/sal
boolean
C0082607 (UMLS CUI [1,1])
C0073992 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C2065041 (UMLS CUI [2,1])
C2936789 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Continuous therapeutic procedure | prescription
Item
evidence of continuing therapy: include only patients who receive ≥2 prescriptions for the therapy under study during the outcome year (i.e. ≥1 prescription at the index date and ≥1 other). uk average is 3-4 prescriptions refilled per year, so ≥2 ensures capture of "real-life" data.
boolean
C0087111 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C1521941 (UMLS CUI [2])
Therapy change | fluticasone salmeterol
Item
evidence of switching for economic reasons: fp/sal patients from practices with ≥5 switches to fostair in a 3 month period to minimise data taken from switching of anomalous patients; optimal practices for inclusion are those switching "wholesale" for economic reasons.
boolean
C3665894 (UMLS CUI [1])
C0082607 (UMLS CUI [2,1])
C0073992 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Chronic disease of respiratory system
Item
any chronic respiratory disease other than asthma
boolean
C0264220 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
Oral steroid therapy
Item
are receiving maintenance oral steroid therapy during baseline period
boolean
C0001617 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial